BioSyent Statistics
Total Valuation
BioSyent has a market cap or net worth of 97.16 million. The enterprise value is 85.15 million.
| Market Cap | 97.16M |
| Enterprise Value | 85.15M |
Important Dates
The next estimated earnings date is Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | May 30, 2025 |
Share Statistics
| Current Share Class | 11.25M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.77% |
| Shares Change (QoQ) | -1.69% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.58M |
Valuation Ratios
The trailing PE ratio is 17.86.
| PE Ratio | 17.86 |
| Forward PE | n/a |
| PS Ratio | 3.65 |
| PB Ratio | 3.88 |
| P/TBV Ratio | 4.48 |
| P/FCF Ratio | 20.12 |
| P/OCF Ratio | 19.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.87, with an EV/FCF ratio of 17.63.
| EV / Earnings | 15.65 |
| EV / Sales | 3.04 |
| EV / EBITDA | 10.87 |
| EV / EBIT | 11.53 |
| EV / FCF | 17.63 |
Financial Position
The company has a current ratio of 4.90, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.90 |
| Quick Ratio | 3.90 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.14 |
| Interest Coverage | 177.97 |
Financial Efficiency
Return on equity (ROE) is 22.17% and return on invested capital (ROIC) is 17.33%.
| Return on Equity (ROE) | 22.17% |
| Return on Assets (ROA) | 15.23% |
| Return on Invested Capital (ROIC) | 17.33% |
| Return on Capital Employed (ROCE) | 27.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.93 |
| Inventory Turnover | 1.50 |
Taxes
In the past 12 months, BioSyent has paid 1.89 million in taxes.
| Income Tax | 1.89M |
| Effective Tax Rate | 25.74% |
Stock Price Statistics
The stock price has increased by +15.75% in the last 52 weeks. The beta is 0.44, so BioSyent's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +15.75% |
| 50-Day Moving Average | 8.24 |
| 200-Day Moving Average | 7.95 |
| Relative Strength Index (RSI) | 59.13 |
| Average Volume (20 Days) | 1,760 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSyent had revenue of 26.63 million and earned 5.44 million in profits. Earnings per share was 0.46.
| Revenue | 26.63M |
| Gross Profit | 20.91M |
| Operating Income | 7.02M |
| Pretax Income | 7.33M |
| Net Income | 5.44M |
| EBITDA | 7.35M |
| EBIT | 7.02M |
| Earnings Per Share (EPS) | 0.46 |
Balance Sheet
The company has 12.11 million in cash and 688,919 in debt, giving a net cash position of 11.42 million.
| Cash & Cash Equivalents | 12.11M |
| Total Debt | 688,919 |
| Net Cash | 11.42M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.05M |
| Book Value Per Share | 2.23 |
| Working Capital | 15.86M |
Cash Flow
In the last 12 months, operating cash flow was 4.86 million and capital expenditures -34,408, giving a free cash flow of 4.83 million.
| Operating Cash Flow | 4.86M |
| Capital Expenditures | -34,408 |
| Free Cash Flow | 4.83M |
| FCF Per Share | n/a |
Margins
Gross margin is 78.51%, with operating and profit margins of 26.35% and 20.43%.
| Gross Margin | 78.51% |
| Operating Margin | 26.35% |
| Pretax Margin | 27.52% |
| Profit Margin | 20.43% |
| EBITDA Margin | 27.59% |
| EBIT Margin | 26.35% |
| FCF Margin | 18.13% |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 1.59%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 1.59% |
| Dividend Growth (YoY) | 8.65% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 27.09% |
| Buyback Yield | 2.77% |
| Shareholder Yield | 4.36% |
| Earnings Yield | 5.60% |
| FCF Yield | 4.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioSyent has an Altman Z-Score of 13.92 and a Piotroski F-Score of 4.
| Altman Z-Score | 13.92 |
| Piotroski F-Score | 4 |